Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Front Vet Sci ; 10: 1169644, 2023.
Article in English | MEDLINE | ID: covidwho-2288952
2.
Viruses ; 12(7)2020 06 28.
Article in English | MEDLINE | ID: covidwho-627994

ABSTRACT

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A virus (IAV), and norovirus (NV) are highly contagious pathogens that threaten human health. Here we focused on the antiviral potential of the medicinal herb, Saxifraga spinulosa (SS). Water-soluble extracts of SS were prepared, and their virus-inactivating activity was evaluated against the human virus pathogens SARS-CoV-2 and IAV; we also examined virucidal activity against feline calicivirus and murine norovirus, which are surrogates for human NV. Among our findings, we found that SS-derived gallocatechin gallate compounds were capable of inactivating all viruses tested. Interestingly, a pyrogallol-enriched fraction (Fr 1C) inactivated all viruses more rapidly and effectively than did any of the component compounds used alone. We found that 25 µg/mL of Fr 1C inactivated >99.6% of SARS-CoV-2 within 10 s (reduction of ≥2.33 log10 TCID50/mL). Fr 1C resulted in the disruption of viral genomes and proteins as determined by gel electrophoresis, electron microscopy, and reverse transcription-PCR. Taken together, our results reveal the potential of Fr 1C for development as a novel antiviral disinfectant.


Subject(s)
Antiviral Agents/pharmacology , Betacoronavirus/drug effects , Influenza A virus/drug effects , Norovirus/drug effects , Plant Extracts/pharmacology , Plants, Medicinal , Saxifragaceae , Betacoronavirus/ultrastructure , Calicivirus, Feline/drug effects , Electrophoresis, Polyacrylamide Gel , Genome, Viral/drug effects , Hemagglutination Tests , Humans , Microscopy, Electron, Transmission , Reverse Transcriptase Polymerase Chain Reaction , SARS-CoV-2 , Viral Proteins/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL